Cargando…
Nucleoside-lipid-based nanocarriers for methylene blue delivery: potential application as anti-malarial drug
Nucleolipid supramolecular assemblies are promising Drug Delivery Systems (DDS), particularly for nucleic acids. Studies based on negatively and positively charged nucleolipids (diC16dT and DOTAU, respectively) demonstrated appropriate stability, safety, and purity profile to be used as DDS. Methyle...
Autores principales: | Kowouvi, Koffi, Alies, Bruno, Gendrot, Mathieu, Gaubert, Alexandra, Vacher, Gaelle, Gaudin, Karen, Mosnier, Joel, Pradines, Bruno, Barthelemy, Philippe, Grislain, Luc, Millet, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064961/ https://www.ncbi.nlm.nih.gov/pubmed/35516884 http://dx.doi.org/10.1039/c9ra02576f |
Ejemplares similares
-
Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery
por: Benizri, Sebastien, et al.
Publicado: (2018) -
Methylene Blue-Based Combination Therapy with Amodiaquine Prevents Severe Malaria in an Experimental Rodent Model
por: Dormoi, Jérôme, et al.
Publicado: (2022) -
Methylene blue inhibits replication of SARS-CoV-2 in vitro
por: Gendrot, Mathieu, et al.
Publicado: (2020) -
Absence of Association between Methylene Blue Reduced Susceptibility and Polymorphisms in 12 Genes Involved in Antimalarial Drug Resistance in African Plasmodium falciparum
por: Gendrot, Mathieu, et al.
Publicado: (2021) -
In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2021)